Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 46  |  Issue : 2  |  Page : 46-48

The association between glycemic control and non-high density lipoprotein cholesterol in type 2 diabetic patients


1 Department of Biochemistry, KAHER (Deemed-to-be-University), Jawaharlal Nehru Medical College, Belagavi, Karnataka, India
2 Department of General Medicine, KAHER (Deemed-to-be-University), Jawaharlal Nehru Medical College, Belagavi, Karnataka, India

Correspondence Address:
Dr. Chetana Prabhu Hadimani
Department of Biochemistry, KAHER (Deemed-to-be-University), Jawaharlal Nehru Medical College, Belagavi, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jss.JSS_12_19

Rights and Permissions

Introduction: Diabetes mellitus (DM) is a group of common metabolic disorders that is characterized by hyperglycemia. It is reported that most patients with Type 2 diabetes could have dyslipidemia at varying degrees, characterized by the increased levels of triglycerides (TGs) and low-density lipoprotein-cholesterol (LDL-C) and decreased high-density lipoprotein-cholesterol (HDL-C). The non-HDL-C was introduced to refine the risk estimation beyond LDL-C in the presence of elevated TGs levels ≥200 mg/dl, and it also estimates the level of all Apo-B-carrying lipoproteins. This study was conducted to correlate the glycated hemoglobin with non-HDL-C and lipid profile in Type 2 DM and non-DM patients. Materials and Methods: The present case and control study was conducted on 204 participants who attended the Medical Outpatient Department at KLE's Hospital, Belagavi, Karnataka, India. 102 Type 2 diabetic patients and 102 age- and gender-matched healthy controls were evaluated for serum fasting blood sugar (FBS), blood HbA1c, serum fasting lipid profile, and non-HDL-C. Data were analyzed using the SPSS software version. 20. Results: The results of our study showed that the mean ± standard deviation levels of FBS were 157.18 ± 41.8 and HbA1c was 8.19 ± 1.68, which were significantly increased in Type 2 diabetes patients as compared to controls with FBS 99.96 ± 12.94 and HbA1C 5.56 ± 0.40 with P < 0.05. The levels of total cholesterol, LDL-C, and TGs significantly increased in cases as compared to controls with P < 0.05. Whereas, non-HDL-C levels significantly increased in cases 147.75 ± 30.42 as compared to controls 111.26 ± 31.9 with P < 0.05. Conclusion: The result of this study showed that HbA1c was associated with a significant increase in non-HDL levels in cases as compared to controls. Thus, non-HDL-C preferred as one of the markers for diabetic dyslipidemia and cardiovascular risk marker than LDL alone.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed662    
    Printed42    
    Emailed0    
    PDF Downloaded57    
    Comments [Add]    

Recommend this journal